Skip Navigation


Nucleic Acids Research Advance Access first published online on January 9, 2008
This version published online on January 18, 2008

Nucleic Acids Research, doi:10.1093/nar/gkm1157
This Article
Right arrow Full Text Freely available
Right arrow Print PDF (2045K) Freely available
Right arrow Screen PDF (287K) Freely available
Right arrowOA All Versions of this Article:
36/4/1300    most recent
gkm1157v2
gkm1157v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Tolentino, J. H.
Right arrow Articles by Basu, A. K.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tolentino, J. H.
Right arrow Articles by Basu, A. K.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2008 The Author(s)
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.


Molecular Biology

Inhibition of DNA replication fork progression and mutagenic potential of 1, N6-ethenoadenine and 8-oxoguanine in human cell extracts

Joel H. Tolentino1, Tom J. Burke2, Suparna Mukhopadhyay2, W. Glenn McGregor2,* and Ashis K. Basu1

1Department of Chemistry, University of Connecticut, Storrs CT 06269 and 2Department of Pharmacology and Toxicology, University of Louisville, Louisville KY 40202, USA

*To whom correspondence should be addressed. Tel: 502 852 2564; Fax: 502 852 2492; Email: wgmcgregor{at}louisville.edu Correspondence may also be addressed to Ashis K. Basu. Tel: 860 486 3965; Fax: 860 486 2981; Email: ashis.basu{at}uconn.edu The authors wish it to be known that, in their opinion, the first two authors should be regarded as joint First Authors.

Received August 24, 2007. Revised November 11, 2007. Accepted December 14, 2007.

Comparative mutagenesis of 1,N6-ethenoadenine ({varepsilon}A) and 8-oxoguanine (8-oxoG), two endogenous DNA lesions that are also formed by exogenous DNA damaging agents, have been evaluated in HeLa and xeroderma pigmentosum variant (XPV) cell extracts. Two-dimensional gel electrophoresis of the duplex M13mp2SV vector containing these lesions established that there was significant inhibition of replication fork movement past {varepsilon}A, whereas 8-oxoG caused only minor stalling of fork progression. In extracts of HeLa cells, {varepsilon}A was weakly mutagenic inducing all three base substitutions in approximately equal frequency, whereas 8-oxoG was 10-fold more mutagenic inducing primarily G->T transversions. These data suggest that 8-oxoG is a miscoding lesion that presents a minimal, if any, block to DNA replication in human cells. We hypothesized that bypass of {varepsilon}A proceeded principally by an error-free mechanism in which the undamaged strand was used as a template, since this lesion strongly blocked fork progression. To examine this, we determined the sequence of replication products derived from templates in which a G was placed across from the {varepsilon}A. Consistent with our hypothesis, 93% of the progeny were derived from replication of the undamaged strand. When translesion synthesis occurred, {varepsilon}A->T mutations increased 3-fold in products derived from the mismatched {varepsilon}A: G construct compared with those derived from the {varepsilon}A: T construct. More efficient repair of {varepsilon}A in the {varepsilon}A: T construct may have been responsible for lower mutation frequency. Primer extension studies with purified pol {eta} have shown that this polymerase is highly error-prone when bypassing {varepsilon}A. To examine if pol {eta} is the primary mutagenic translesion polymerase in human cells, we determined the lesion bypass characteristics of extracts derived from XPV cells, which lack this polymerase. The {varepsilon}A: T construct induced {varepsilon}A->G and {varepsilon}A->C mutant frequencies that were approximately the same as those observed using the HeLa extracts. However, {varepsilon}A->T events were increased 5-fold relative to HeLa extracts. These data support a model in which pol {eta}-mediated translesion synthesis past this adduct is error-free in the context of semiconservative replication in the presence of fidelity factors such as PCNA.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.